Under the terms of the partnership, AITRICS gains access to Mayo Clinic’s extensive clinical data, enabling the development of AI models tailored for diverse medical settings. This collaboration provides a robust foundation for validating the performance and safety of these models on an international scale, ensuring they meet rigorous standards for clinical application.
The agreement also establishes a strategic partnership encompassing intellectual property rights and distribution, laying the groundwork for long-term collaboration from research to commercialization. AITRICS aims to leverage this alliance to accelerate its expansion into the U.S. and other global markets.
The Mayo Clinic Platform, renowned for its vast clinical data and research capabilities, offers a premier infrastructure for developing and evaluating medical AI. This partnership is poised to serve as a critical catalyst for AITRICS’ entry into the U.S. healthcare market, a key milestone in its global strategy.
“This agreement is a pivotal starting point for our global market ambitions and an opportunity to broaden our collaborative scope,” said Xia Park, AITRICS’ manager of overseas business development. “Through our partnership with Mayo Clinic, we will execute a tailored U.S. strategy and achieve sustainable growth.”
The collaboration underscores the growing role of AI in transforming healthcare delivery, with AITRICS positioning itself as a leader in this rapidly evolving field.
Kim Kuk Ju, HEALTH IN NEWS TEAM
press@hinews.co.kr
